Funded primarily by the Jayne Koskinas Ted Giovanis Foundation and the National Institutes of Health, and leveraging prior ...

Overview of Prenatal Genetic Testing MarketThe global Prenatal Genetic Testing Market is valued at USD 7.01 Billion in 2024 ...

Massimo Cristofanilli, MD, discusses the role of cell-free DNA in breast cancer. In an interview with Targeted Oncology TM, Massimo Cristofanilli, MD, medical oncologist at the Breast Center at Weill ...

Article citations More>> Tounta, G., Vrettou, C., Kolialexi, A., Papantoniou, N., Destouni, A., Tsangaris, G.T., et al. (2011) A Multiplex PCR for Non-Invasive Fetal RHD Genotyping Using Cell-free ...

Researchers from Geneseeq and a network of Chinese academic hospitals have validated a blood test that can detect a broad range of cancers with high accuracy using cell-free DNA. A multi-cancer ...

MCD tests should demonstrate high specificity, clinically meaningful sensitivity, and provide information to guide clinical diagnostic evaluation. Methods: We developed an MCD test that leverages a ...

The 14-gene offering is a combination of 5-gene carrier screening panel, 8-gene carrier screening panel, Fragile X testing, and cell-free DNA test for fetal risk assessment when a pregnant mother is ...

One of the most important advances is the use of cell-free fetal DNA testing between 10 and 12 weeks of pregnancy. This simple blood test can identify whether the baby has red cell antigens that may ...

Cell-free DNA testing uses a small amount of a person's blood and tests it for a large number of cancers. A positive test could indicate that the person has a certain type of cancer in theory ...

In a pregnant person, some of this cell-free DNA is fetal DNA from the placenta. In the epiphany that spawned NIPT, Hong Kong–based researcher Dennis Lo realized that even though fetal DNA is ...

Donor-derived cell-free DNA can aid detection, diagnosis, and monitoring of antibody-mediated rejection after kidney transplantation.